Literature DB >> 10639473

Candida albicans-derived beta-1,2-linked mannooligosaccharides induce desensitization of macrophages.

T Jouault1, C Fradin, P A Trinel, D Poulain.   

Abstract

Candida albicans beta-1,2-oligomannosides stimulate macrophage tumor necrosis factor alpha (TNF-alpha) but not NO release. This stimulation desensitized macrophages by altering beta-1, 2-oligomannoside-dependent TNF-alpha production and lipopolysaccharide-dependent TNF-alpha and NO secretion. Desensitization was not related to tyrosine phosphorylation signal transduction but was transferred by culture supernatants in which arachidonic acid derivatives were evidenced.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10639473      PMCID： PMC97232          DOI： 10.1128/IAI.68.2.965-968.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  30 in total

1.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

3.  Differential effects of tyrosine kinase inhibitors on tumor necrosis factor and nitric oxide production by murine macrophages.

Authors:  S L Orlicek; E Meals; B K English
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

Review 4.  Lipid mediator networks in cell signaling: update and impact of cytokines.

Authors:  C N Serhan; J Z Haeggström; C C Leslie
Journal:  FASEB J       Date:  1996-08       Impact factor: 5.191

5.  LPS pretreatment reprograms macrophage LPS-stimulated TNF and IL-1 release without protein tyrosine kinase activation.

Authors:  M A West; T Bennet; S C Seatter; L Clair; J Bellingham
Journal:  J Leukoc Biol       Date:  1997-01       Impact factor: 4.962

6.  Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide.

Authors:  S M Levitz; A Tabuni; S H Nong; D T Golenbock
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production.

Authors:  T Jouault; G Lepage; A Bernigaud; P A Trinel; C Fradin; J M Wieruszeski; G Strecker; D Poulain
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  The Candida albicans phospholipomannan induces in vitro production of tumour necrosis factor-alpha from human and murine macrophages.

Authors:  T Jouault; A Bernigaud; G Lepage; P A Trinel; D Poulain
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

9.  Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection.

Authors:  A Cassone; M Boccanera; D Adriani; G Santoni; F De Bernardis
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

10.  Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.

Authors:  A Vecchiarelli; C Retini; D Pietrella; C Monari; C Tascini; T Beccari; T R Kozel
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441
View more
  8 in total

1.  NK cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis.

Authors:  José Juan Gaforio; Elena Ortega; Ignacio Algarra; María José Serrano; Gerardo Alvarez de Cienfuegos
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans.

Authors:  Françoise Dromer; Reynald Chevalier; Boualem Sendid; Luce Improvisi; Thierry Jouault; Raymond Robert; Jean Maurice Mallet; Daniel Poulain
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Evaluation of immunostimulatory activities of synthetic mannose-containing structures mimicking the β-(1->2)-linked cell wall mannans of Candida albicans.

Authors:  Kaarina Ranta; Kaisa Nieminen; Filip S Ekholm; Moniká Poláková; Mattias U Roslund; Tiina Saloranta; Reko Leino; Johannes Savolainen
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

4.  beta-1,2-linked oligomannosides from Candida albicans bind to a 32-kilodalton macrophage membrane protein homologous to the mammalian lectin galectin-3.

Authors:  C Fradin; D Poulain; T Jouault
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 5.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens.

Authors:  Kieren A Marr; S Arunmozhi Balajee; Thomas R Hawn; Adrian Ozinsky; Uyenvy Pham; Shizuo Akira; Alan Aderem; W Conrad Liles
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

7.  Contribution of phospholipomannan to the surface expression of beta-1,2-oligomannosides in Candida albicans and its presence in cell wall extracts.

Authors:  D Poulain; C Slomianny; T Jouault; J M Gomez; P A Trinel
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

8.  Actin and phosphoinositide recruitment to fully formed Candida albicans phagosomes in mouse macrophages.

Authors:  Sigrid E M Heinsbroek; Lynn A Kamen; Philip R Taylor; Gordon D Brown; Joel Swanson; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-11-12       Impact factor: 7.349
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.